MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome

Table 1 Patient cohort

Clinical Variable	All	High-Grade Serous^a	Clear Cell	Endometrioid	Mucinous	Low-Grade Serous^b
No. cases (% of total)	289 (100%)	176 (61%)	8 (3%)	22 (8%)	49 (17%)	34 (12%)
Median Age (years)	58.8	60.4	56.1	54.3	57.5	46.4
Benign	7	0	0	0	7	0
Borderline	61	0	0	22	32	27
Stage I^c	79	11	6	14	35	13
Stage II	16	7	0	4	1	4
Stage III	155	131	2	1	5	16
Stage IV	30	27	0	2	0	1
Grade 1^d	22	0	N/A	8	7	7
Grade 2	85	78	N/A	5	2	0
Grade 3	106	98	N/A	7	1	0
Residual Disease ≤ 1 cm^e	151	84	1	9	34	23
Residual Disease >1 cm	137	91	7	13	15	11
Deceased	146	126	2	5	9	4

^aIncludes one tumour of mixed histology of which serous was the predominant type.
^bBorderline serous tumours are included in the low-grade serous column.
^cStaging information missing for 2 patients (no staging for benign tumours).
^dClear cell carcinomas were not graded.
^eResidual disease information missing for 1 patient.

ISSN: 1471-2407